Search Results

Containing any of the words

Only of the type

SFDA Participates in The Occupation Day for the 7th Batch of The Custodian of The Two Holy Mosques Scholarship Students Abroad News

Effect of Initial Combination Therapy With Sitagliptin, and Metformin on Glycemic Control in Patients With Type 2 Diabetes Awareness Article

An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia Drug Clinical Trial

"Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4700 for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Healthy" Drug Clinical Trial

A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight related complications or risk factors for CVD Drug Clinical Trial

(SG-1909-105-H) Recommendations for increasing the efficacy and reliability of FreeStyle Libre 14 Day Flash Glucose Monitoring) Medical Report

A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin Drug Clinical Trial

"CLCZ696B2401-TRANSITION (A multicenter, randomized, open label, parallel group studycomparing pre-discharge and posT-discharge tReatmentinitiation with LCZ696 in heArt failure patieNtS withreduced ejectIon-fracTion hospItalized for an acutedecOmpensation eveNt (ADHF)" Drug Clinical Trial

A phase 3, multi-center, open-label, randomized study of oral ABL001 versus bosutinib in patients with Chronic Myelogenous Leukemia in chronic phase (CML-CP), previously treated with 2 or more tyrosine kinase inhibitors Drug Clinical Trial

Open Label, Multinational, Multicenter, Real World Treatment Study of Single Agent AZD9291 for Patients with Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR)T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Who Have Received Prior Therapy with an EGFR Tyrosine Kinase Inhibitor(EGFR-TKI) Drug Clinical Trial